UNSPSC 51111622: Adenine

This classification denotes a purine with the molecular formula C5H5N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JAC85A2161, chemically known as 3,6-dihydro-6-iminopurine but generally known as adenine, which bears US NIH Compound Identifier 190. Adenine comes in many forms, including arabinoside, deoxyribonucleoside, deoxyribose, dihydroiodide, hemisulfate, hydrochloride, nucleoside, octosyl acid, phosphate, propenal, riboside, sulfate, and xyloside.

UNSPSC 51111622 Adenine, a Commodity code, addresses pharmaceutical active ingredients and precursors that state and local health agencies procure for pharmacy benefit programs and direct-to-manufacturer prescription initiatives. The recent activity under this code centers on state health and human services departments seeking to establish direct contracting relationships with pharmaceutical manufacturers and vendors to manage prescription fulfillment and cost control outside traditional pharmacy benefit manager (PBM) and group purchasing organization (GPO) channels. State health agencies—particularly state health and human services commissions—are the primary issuing bodies soliciting under this code, using exploratory procurement mechanisms such as Requests for Information to gather vendor capabilities and market intelligence before formal competitive solicitation.

Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor responses regarding implementation of a Therapeutic Pharmacy Initiative (TPI) Direct-to-Manufacturer Prescriptions program. The RFI solicited detailed information about vendors' experience with direct contracting for self-insured employers and health plans in both private and government sectors, their capacity to negotiate contracts based on negotiated net pricing models without rebates, and their ability to implement value-based or outcomes-based agreements. The RFI was designed as a preliminary market intelligence tool to inform the state's future procurement strategy and program design before issuing a formal RFP with established financial and temporal parameters. No award value, budget range, or specific response timeline beyond the April 3 deadline was identified in the RFI materials.